Ch. Lin et al., Advanced glycosylation end products induce nitric oxide synthase expression in C6 glioma cells - Involvement of a p38 MAP kinase-dependent mechanism, LIFE SCI, 69(21), 2001, pp. 2503-2515
The mitogen-activated protein kinase (MAPK) pathway is believed to function
as an important mediator of inducible nitric oxide synthase (iNOS) express
ion. In the present study, we investigated the role of the p38 MAPK signali
ng pathway in advanced glycosylation end products (AGEs)-induced iNOS expre
ssion in C6 glioma cells. AGEs caused a dose-dependent increase of nitrite
accumulation in C6 glioma cells. The AGEs-stimulated nitrite production fro
m C6 glioma cells was inhibited by actinomycin D, cyclohexamide, and the NO
synthase inhibitor, N.-nitro-L-arginine methyl ester (L-NAME), suggesting
that the increase of AGEs-induced nitrite release is due to iNOS up-regulat
ion. Consistently, treatment of C6 glioma cells with AGEs induced iNOS prot
ein expression. AGEs-stimulated nitrite production was inhibited by pretrea
tment of C6 glioma cells with anti-AGEs antibodies (1:100 or 1:50). The tyr
osine kinase inhibitor (genistein and tyrphostin), the Ras-farnesyl transfe
rase inhibitor (FPT inhibitor-II), or the p38 MAPK inhibitor (SB203580) sup
pressed AGEs-induced iNOS expression and nitrite release from C6 glioma cel
ls. AGEs activated p38 MAPK in C6 glioma cells, and this effect was blocked
by genistein (20 muM), tyrphostin (30 muM), FPT inhibitor-II (20 muM), and
SB203580 (10 muM). Taken together, our data suggest that AGEs may activate
the pathways of tyrosine kinase and Ras to induce p38 MAPK activation, whi
ch in turn induces iNOS expression and NO production in C6 glioma cells. (C
) 2001 Elsevier Science Inc. All rights reserved.